499 related articles for article (PubMed ID: 7621989)
1. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
Unger RH
Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
[TBL] [Abstract][Full Text] [Related]
2. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
Lee Y; Hirose H; Zhou YT; Esser V; McGarry JD; Unger RH
Diabetes; 1997 Mar; 46(3):408-13. PubMed ID: 9032096
[TBL] [Abstract][Full Text] [Related]
3. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
Hirose H; Lee YH; Inman LR; Nagasawa Y; Johnson JH; Unger RH
J Biol Chem; 1996 Mar; 271(10):5633-7. PubMed ID: 8621426
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.
Lee Y; Hirose H; Ohneda M; Johnson JH; McGarry JD; Unger RH
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10878-82. PubMed ID: 7971976
[TBL] [Abstract][Full Text] [Related]
5. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
Shimabukuro M; Zhou YT; Levi M; Unger RH
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids.
Milburn JL; Hirose H; Lee YH; Nagasawa Y; Ogawa A; Ohneda M; BeltrandelRio H; Newgard CB; Johnson JH; Unger RH
J Biol Chem; 1995 Jan; 270(3):1295-9. PubMed ID: 7836394
[TBL] [Abstract][Full Text] [Related]
8. Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM.
Man ZW; Zhu M; Noma Y; Toide K; Sato T; Asahi Y; Hirashima T; Mori S; Kawano K; Mizuno A; Sano T; Shima K
Diabetes; 1997 Nov; 46(11):1718-24. PubMed ID: 9356017
[TBL] [Abstract][Full Text] [Related]
9. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
10. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
Zhou YP; Berggren PO; Grill V
Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
12. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Zhou YP; Cockburn BN; Pugh W; Polonsky KS
Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in obesity-induced beta cell disease.
Shimabukuro M; Ohneda M; Lee Y; Unger RH
J Clin Invest; 1997 Jul; 100(2):290-5. PubMed ID: 9218505
[TBL] [Abstract][Full Text] [Related]
15. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
Mason TM; Goh T; Tchipashvili V; Sandhu H; Gupta N; Lewis GF; Giacca A
Diabetes; 1999 Mar; 48(3):524-30. PubMed ID: 10078552
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids-the link between obesity and insulin resistance.
Boden G
Endocr Pract; 2001; 7(1):44-51. PubMed ID: 11250769
[TBL] [Abstract][Full Text] [Related]
18. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
[TBL] [Abstract][Full Text] [Related]
19. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F
Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481
[TBL] [Abstract][Full Text] [Related]
20. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
